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Abstract
The development and optimization of a palladium-catalyzed asymmetric conjugate addition of 
arylboronic acids to cyclic enone conjugate acceptors is described. These reactions employ air-
stable and readily-available reagents in an operationally simple and robust transformation that 
yields β-quaternary ketones in high yields and enantioselectivities. Notably, the reaction itself is 
highly tolerant of atmospheric oxygen and moisture and therefore does not require the use of dry 
or deoxygenated solvents, specially purified reagents, or an inert atmosphere. The ring size and β-
substituent of the enone are highly variable, and a wide variety of β-quaternary ketones can be 
synthesized. More recently, the use of NH4PF6 has further expanded the substrate scope to include 
heteroatom-containing arylboronic acids and β-acyl enone substrates.
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1. Introduction
Synthesis of all-carbon quaternary stereocenters by means of asymmetric catalysis remains a 
challenging problem in synthetic chemistry.1 Historically, the 1,4 addition of a nucleophile 
to a suitable α,β-unsaturated conjugate acceptor has been a reliable means of synthesizing 
these challenging quaternary stereocenters.2 Many groups have pioneered methods for this 
transformation employing highly reactive organometallic reagents (e.g., diorganozinc,3 
triorganoaluminum, 4 and organomagnesium reagents5) to react with a large array of 
electrophiles under copper catalysis. Rigorously anhydrous conditions are a requirement of 
these approaches, as they uniformly utilize water-sensitive reagents. As an alternative, 
Hayashi developed chiral rhodium complexes that successfully catalyze the asymmetric 
conjugate addition of various organoboron reagents to conjugate acceptors in very high 
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yields and enantioselectivities. 6,7 More recently, the rhodium system has been expanded to 
include syntheses of quaternary stereocenters.8 In particular, the development of chiral diene 
ligands has facilitated the rhodium-catalyzed conjugate addition of sodium tetraaryl borates 
(Ar4BNa) and arylboroxines (ArBO)3 to enones to afford products containing all-carbon 
quaternary stereocenters.9,10 However, it should be noted that these reactions cannot use 
common and commercially available arylboronic acids.9-11
Upon undertaking studies to develop a palladium-catalyzed asymmetric conjugate addition 
capable of synthesizing quaternary stereocenters, we noted that there were only examples of 
asymmetric synthesis of tertiary stereocenters in the palladium literature.12 Concurrent with 
our early studies, Lu and co-workers reported that the dicationic complex 
[(bpy)Pd(OH)]2·2BF4 was capable of catalyzing the conjugate addition of arylboronic acids 
to 3-methylcyclohexenone to synthesize racemic products featuring quaternary 
stereocenters.13 In 2011, we reported the discovery of an asymmetric palladium-catalyzed 
conjugate addition based on a catalyst derived in situ from Pd(OCOCF3)2 and a chiral 
pyridinooxazoline (PyOx) ligand.14 These reactions were demonstrated on a broad spectrum 
of arylboronic acid and enone substrates, and were found to be remarkably tolerant of both 
oxygen and water. Subsequently, we disclosed the use of NH4PF6 and water as synergistic 
additives to accelerate the rate of the reaction. Fortuitously, these additives also allowed 
reactions to be conducted at temperatures as low as ambient temperature.15
Herein, we discuss report a full account of the development of these reactions and discuss 
the full scope of the chemistry to date.
2. Development and optimization of reaction conditions
2.1. Identification of chemically competent ligand and reaction conditions
To achieve the desired enantioselective conjugate addition, the reaction of 3-
methylcyclohexen-2-one (1) with phenylboronic acid (2) was investigated in the presence of 
various palladium catalysts and chiral ligands (Table 1). We hypothesized dinitrogen ligands 
that were less sterically bulky than large arylphosphine ligands would successfully 
synthesize the highly congested quaternary stereocenter of β-disubstituted ketone 3, and 
were pleased to find that bipyridine (bpy, 4) enabled full conversion of enone 1 when treated 
with palladium(II) acetate and phenylboronic acid in protic solvents. Unfortunately, a 
number of other standard ligand scaffolds failed to afford any conversion to the desired 
conjugate addition product under identical reaction conditions. Sparteine (6), PyBox (7), and 
a variety of bis-oxazoline (9 and 10) and phosphinooxazoline (8) did not enable the 
transformation. ‘Ligand-free’ conditions (5) also failed to provide any product. Notably, 
pyridine (11, 12 mol %, 2 equiv) failed to deliver any product, insinuating that architectural 
features of the bidentate bpy scaffold enabled the desired reaction.
Success with bpy and lack of success with chiral bis-oxazoline ligands led us to propose that 
a C1 symmetry chiral ligand based on the bpy scaffold would be a suitable catalyst. The 
presence of a pyridine ring was required, however the small bite angle and five-membered 
metallocycle chelate seemed equally important. We reasoned that modification of one 
pyridine moiety of bpy would allow for the introduction of a chiral group (Fig. 1, 
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hypothetical ligand 12), while still maintaining the five-membered chelate and narrow bite-
angle. We quickly discovered that substituted pyridinooxazoline ligands (13)14 provided 
high levels of enantioselection.
Identification of a functioning chiral ligand ((S)-t-BuPyOx, 14) prompted us to consider the 
effects of solvent on the yield and enantioselectivity of the reaction. A preliminary solvent 
screen led us to observe that polar, coordinating solvents hindered the reaction (Table 2, 
entries 1–3). Moving toward non-polar solvents, such as toluene (entry 4), encouraged 
higher conversions and modest enantioinduction, however, heating these reactions (entries 6 
and 7) failed to drive the reactions to full conversion. Fortuitously, dichloromethane (entry 
5) provided 87% isolated yield of the desired conjugate addition adduct in 91% ee.
To further optimize the reaction, we next looked at the effect of different palladium sources. 
The use of palladium(II) halides afforded no reaction (Table 3, entries 1 and 2). The 
reactivity could be rescued via halogen abstraction upon treatment with AgOTf (entry 3), 
however, this reaction produced ketone 3 in low enantioselectivity. In the presence of ligand 
14, palladium(II) carboxylate sources were capable of catalyzing the desired reaction 
(entries 4 and 5). The acetate counterion (entry 4) led to modest chemical yields of the 
desired conjugate addition adduct in 93% ee. A catalyst derived from palladium(II) 
trifluoroacetate and pyridinooxazoline 14 produced the desired ketone product 316 in 87% 
yield and 91% ee (entry 5).17 By using 1,2-dichloroethane in place of dichloromethane as 
solvent, and increasing the reaction temperature from 40 to 60 °C, ketone 3 was isolated in 
99% yield and 93% ee (entry 6). The high yield and enantioselectivity were maintained even 
upon addition of 10 equiv of water (entry 7). Furthermore, the amount of phenylboronic acid 
was reduced to 1.1 equiv with no detrimental effects (entry 8).
A final examination of solvent and palladium sources was undertaken following the 
disclosure of a highly enantioselective palladium-catalyzed conjugate addition by Minnaard 
and coworkers whereby a dicationic palladium catalyst is generated in MeOH.18 However, 
we found that highly polar solvents failed to produce product (Table 4, entries 2 and 3). 
Switching to dicationic palladium by employing tetrakis acetonitrile palladium(II) 
tetrafluoroborate facilitated no conversion in methanol at a variety of temperatures (entries 
4–6), or as a mixture with dichloroethane as cosolvent (entry 6). Finally, we failed to 
generate a catalyst in situ from isolated (PyOx)PdCl2 by treatment with sodium 
hexafluorophosphate (entry 7).
2.2. Identification of chemically competent ligand and solvent conditions
Having successfully optimized the reaction conditions, we next examined the reaction with 
other members of the PyOx or related quinolinooxazoline (QuinOx) ligand series (Table 5, 
17 and 18). Ligands with electron-donating (15) or electron-withdrawing (16) substituents 
on the pyridine moiety both furnished the product in high yield, but with decreased 
enantioselectivity. Next, employing QuinOx ligands 17 or 18 resulted in a dramatic decrease 
in both the reactivity and enantioselectivity, presumably due to poor chelation of palladium 
due to the increased steric bulk adjacent to the pyridine nitrogen. Modifying the chiral 
substituent to groups other than tert-butyl also led to decreased enantioselectivity, as we 
observed PyOx ligands bearing isobutyl (20), phenyl (21), or isopropyl (22) substitution to 
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deliver ketone 3 in quantitative yield, but significantly depressed ee. Similarly, PyOx ligands 
without substitution at the 4-position (19) afford no appreciable enantiocontrol and deliver 
ketone 3 nearly as a racemic mixture.
Following the discovery that the addition of NH4PF6 and water accelerate the reaction (see 
Section 3 for discussion), we reexamined a large number of chiral and achiral ligands to 
determine if the new conditions facilitated an expanded class of ligands to successfully 
catalyze the reaction. Unfortunately, all phosphine ligands we tried failed to achieve 
appreciable conversion (Table 6, 23, 24, and 25). The drop in conversion from dppe (24) to 
dppbz (25) led us to question whether ligand rigidity was detrimental to conversion. 
However, the nearly identical results observed with bpy (4), phenanthroline (26), and 
bathophenanthroline (27) suggest that rigidity of the ligand scaffold has minimal effect on 
conversion.
We screened a number of chiral diamine ligands under the newly optimized conditions as 
well. The best conversion was observed with a bis-oxazoline with a bite angle similar to that 
of bpy (Table 6, 34), followed by proline-derived 32, which also features a five-membered 
metallocycle chelate. Ligands forming six-membered metallocycles (28 and 29) performed 
poorly, however those containing gem-dimethyl (31) or cyclopropyl (35) substituted 
bridging methylene groups showed improved conversion. We believe this to be the result of 
the quaternary center on the ligand backbone enforcing a smaller bite angle. Additionally, 
sparteine (6), PHOX (33), and PyBox (30) ligands delivered no conversion to the desired 
product.
3. Determination of substrate scope
To determine the substrate scope, a wide variety of arylboronic acids were exposed to the 
optimized reaction conditions (Table 7). Generally, para-substituted arylboronic acids react 
with good yields and enantioselectivities. Alkyl substituted products (red colored, Table 7) 
are generally formed in good yield and ee, such as those formed by 4-methyl- and 4-
ethylphenylboronic acids (36 and 37). However, arylboronic acids bearing substituents with 
greater electron-donating capacity, such as 4-benzyloxyphenylboronic acid or 4-
methoxyphenylboronic acid react to form products with diminished yields and 
enantioselectivities (38 and 39). A wide range of functional groups can be utilized 
successfully. Even a silyl ether is tolerated (e.g., 44), however in modest yield. Arylboronic 
acids bearing electron-withdrawing substituents (blue colored) tend to perform extremely 
well. Both 4-acylpheny- and 4-trifluoromethylphenylboronic acids react with quantitative 
yield and 96% ee to form ketones 40 and 41. The product of 4- chlorophenylboronic acid 
(42) is formed in 94% yield and 95% ee, and the product of 4-fluorophenylboronic acid (43) 
is afforded in 92% ee. Finally, meta-substitution on the arylboronic acid also furnishes 
products in high ee and yield. 3-Methylphenylboronic acid and 3-
carbomethoxyphenyboronic acid both afford product ketones (45 and 46, respectively) in 
greater than 90% ee (Table 8).
More recently, we discovered that the addition of NH4PF6 and water accelerate the reaction, 
and allow for lower temperatures to be employed.15 Typically, reactions under these 
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conditions occur between room temperature and 40 °C. Gratifyingly, we discovered that 
these milder conditions facilitate increased yields with substrates that had reacted with good 
ee, but poor yields under the initial reported conditions (in the absence of NH4PF6 and 
water). In some cases, the isolated yield nearly doubled. For example, reaction of 3-
chlorophenylboronic acid saw a yield increase from 55% to 96% yield. Likewise, the 
product formed from 3-bromophenylboronic acid (47b) increased from 44% yield to 84% 
yield. Even 3-nitrophenylboronic acid saw an increase from 40% to 81% yield. Furthermore, 
2-fluorophenylboronic acid reacted with 70% yield and 77% ee under the newly modified 
conditions. In each of these cases, the increase in yield is met with effectively no change in 
ee.
Next, we tested a variety of β-substituted enones to examine the scope of the enone reactant 
(Table 9). A wide variety of alkyl substituted products can be formed, such as ethyl (48), n-
butyl (49), and benzyl (50) substituents at the β-position, all which were afforded in greater 
than 90% ee. Furthermore, branched, bulky alkyl substituents could be successfully utilized, 
forming products such as isopropyl (51), cyclopropyl (52), and cyclohexyl (53). Heteroatom 
linkers (e.g., 54) are suitable β-substituents as well. Finally, products formed from five- and 
seven-membered enones (55 and 56, respectively) were reacted with greater than 90% ee.
4. Plausible catalytic cycle
Computational and experimental work by our group in collaboration with the Houk 
laboratory suggests that the reaction is catalyzed by a palladium(II) cationic species (Fig. 2, 
57).15a We propose that the active catalyst is likely a palladium(II) hydroxide, which are 
known to undergo rapid transmetallation with arylboronic acids.19 Though the precise role 
of NH4PF6 has not been established, we postulate that the presence of the non-coordinating 
counterion may stabilize the cationic intermediates on the proposed catalytic cycle, or 
otherwise favor a resting state, that is, on the productive catalytic cycle. This would have the 
effect of increasing the relative concentration of the active catalyst species, leading to the 
observed rate increase. Rapid reaction of palladium hydroxide 57 with arylboronic acid then 
affords cationic arylpalladium(II) 58. Ligand substitution and substrate coordination, likely 
through the oxygen of the enone to form complex 60, lead to insertion of the aryl-palladium 
bond when coordination via the enone olefin occurs (59). This olefin insertion is the 
enantioselectivity- determining step. The lowest energy diastereomer of this insertion 
reaction has been calculated to be transition state 59-ts,15a which leads to the observed (R) 
stereochemistry of the product ketones. Migratory insertion of the substrate olefin into the 
aryl-palladium bond affords carbon-bound palladium enolate 62, which likely isomerizes to 
its oxygen-bound tautomer, enolate 61. Hydrolysis of this latent cationic palladium enolate 
(61) affords the product ketone (3) and regenerates the catalyst (57).
5. Expanded substrate scope
The discovery that reaction rates were dramatically increased by the addition of 
hexafluorophosphate salts and additional water represented an opportunity to expand the 
substrate scope. The additives promote successful reaction at 40 °C or lower, and thus 
substantially facilitate the reaction of substrates with temperature-sensitive functionalities 
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(such as silyl ethers), or groups that may react with trace palladium(0), that is, formed by 
off-cycle pathways (such as aryl bromides).We next turned our attention to two other 
substrate classes: (1) β-acyl cyclic enones and (2) arylboronic acids containing nitrogen and 
other heteroatoms.
We considered that our β-arylation reaction constituted a synthetically useful means of 
synthesizing asymmetric 1,4-dicarbonyl compounds. Beginning with β-acyl cyclic enones 
(63), we were able to react a variety of arylboronic acids to synthesize asymmetric 1,4-
dicarbonyl compounds (Table 10, 64a–g). Interestingly, only products from the olefin 
insertion that form quaternary stereocenters were observed. The isomeric addition product, 
which would contain vicinal tertiary stereocenters, was not observed in any of the crude 
reaction mixtures by NMR spectroscopy.
Next, we strived to demonstrate that the reaction was tolerant of heteroatom substitution on 
the arylboronic acid. We proposed that aniline-derived boronic acids could be reacted when 
protected with electron-withdrawing functional groups. Cbz-protected aniline boronic acid 
65a reacted with modest yield (Table 11), but a promising 76% ee. Modification to the 
pivaloyl protected boronic acid 65b, facilitated higher yields, but had minimal effect on 
enantioselectivity. Finally, trifluoroacetyl-protected 65c afforded clean conversion to afford 
98% of the conjugate addition adduct 66c in 89% ee. The trifluoroacetyl group facilitated 
the reaction on a number of aniline-derived arylboronic acids, including methoxyphenyl 
trifluoroacetamide 65d, trisubstituted acetamide 65e, and 3-trifluoroacetamides 65f and 65g. 
Their successful reactions demonstrate the broad utility of these substrates.
6. Challenging substrates
Despite the many substrates that undergo facile conjugate addition, a number of substrates 
proved incompatible with the newly developed methodology (Table 12). Pyridine 67 
presumably coordinates palladium and inhibits the catalyst, yielding no conjugate addition 
product. Allyl enone 68 also did not react, nor did enyneone 69. β-Aromatic enones also 
failed, such as thiophene 70 and chloroarene 71. Each of these substrates has functionality 
that can potentially interact with palladium; such interactions are likely detrimental to the 
catalyst.
Some arylboronic acids also proved to be poor nucleophiles. ortho-Substituted arylboronic 
acids were generally poor substrates; 2-chlorophenylboronic acid (Table 13, 73) yielded 
only 2% of its corresponding product in 37% ee, while 2-methylphenylboronic acid (74) 
yielded 13% product in 22% ee. Arylboronic acids with reactive groups, such as iodide 76 
and furan 77, were not successfully employed in conjugate addition chemistry. 
Cyanophenylboronic acid 80 also failed to react. In general, heterocycles are not well 
tolerated, as observed by the lack of reactivity of indole 81. Steric crowding of the reactive 
boronic acid site by the Boc protecting group may play a role in the poor reactivity. 
Likewise, the very electron poor fluoroarene 78 does not react, though steric congestion 
likely contributes to its poor performance as well. Interestingly, styrene moieties 79 and 82 
also did not undergo addition. Additionally, it should be noted that electron-rich arylboronic 
acids (e.g., dimethoxyphenylboronic acid (75)) undergo rapid homocoupling and 
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proteodeborylation under the reaction conditions. Thus, it is difficult to achieve synthetically 
useful yields of these electron-rich adducts. Furthermore, the enantioselectivity seems to be 
lower for these electron-rich arylboronic acids.
7. Conclusion and outlook
In summary, we have developed a widely applicable method for the synthesis of β-
quaternary ketones of a variety of ring sizes utilizing a palladium-catalyzed, asymmetric 
conjugate addition of arylboronic acids to enone electrophiles. A wide array of arylboronic 
acids and enones were successfully employed in this transformation. Critically, the reactions 
are compatible with protic co-solvents, such as water, and display remarkable tolerance to 
atmospheric oxygen. Furthermore, the optimized ligand, (S)-t-BuPyOx (14), is easily 
synthesized and readily prepared on multigram quantities.20 These features, in combination 
with the ease of handling of arylboronic acids, result in an operationally simple reaction with 
a straightforward procedure. All reactions described herein were performed in screw-top 
vials and without purification or distillation of any reagents or solvents. Application of this 
reaction method toward the catalytic asymmetric total synthesis of several natural product 
classes and the development of an asymmetric conjugate addition of heteroaryl substrates 
are currently underway in our laboratory.
8. Experimental section
8.1. Materials and methods
Unless otherwise stated, reactions were performed with no extra precautions taken to 
exclude air or moisture. Commercially available reagents were used as received from 
Sigma–Aldrich unless otherwise stated. Enone substrates (Table 3) were purchased from 
Sigma–Aldrich (3-methylcyclohexenone, 2-cyclohexene-1-one, chromone) or were prepared 
according to literature procedure.21 Pyridinooxazoline ligands were synthesized according to 
literature procedures.22 Reaction temperatures were controlled by an IKAmag temperature 
modulator. Thin-layer chromatography (TLC) was performed using E. Merck silica gel 60 
F254 precoated plates (250 nm) and visualized by UV fluorescence quenching, potassium 
permanganate, or p-anisaldehyde staining. Silicycle SiliaFlash P60 Academic Silica gel 
(particle size 40–63 nm) was used for flash chromatography. Analytical chiral HPLC was 
performed with an Agilent 1100 Series HPLC utilizing a Chiralcel OJ column (4.6 mm×25 
cm) obtained from Daicel Chemical Industries, Ltd with visualization at 254 nm and flow 
rate of 1 mL/min, unless otherwise stated. Analytical chiral SFC was performed with a 
JASCO 2000 series instrument utilizing Chiralpak (AD-H or AS-H) or Chiralcel (OD-H, 
OJ-H, or OB-H) columns (4.6 mm×25 cm), or a Chiralpak IC column (4.6 mm× 10 cm) 
obtained from Daicel Chemical Industries, Ltd with visualization at 210 or 254 nm and flow 
rates of 3 mL/min or 5 mL/min, as indicated below. 1H and 13C NMR spectra were recorded 
on a Varian Inova 500 (500 MHz and 125 MHz, respectively) and a Varian Mercury 300 
spectrometer (300 MHz and 75 MHz, respectively). Data for 1H NMR spectra are reported 
as follows: chemical shift (δ ppm) (multiplicity, coupling constant (Hz), integration). Data 
for 1H NMR spectra are referenced to the centerline of CDCl3 (δ 7.26) as the internal 
standard and are reported in terms of chemical shift relative to Me4Si (δ 0.00). Data for 13C 
NMR spectra are referenced to the centerline of CDCl3 (δ 77.0) and are reported in terms of 
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chemical shift relative to Me4Si (δ 0.00). Infrared spectra were recorded on a Perkin–Elmer 
Paragon 1000 Spectrometer and are reported in frequency of absorption (cm−1). High-
resolution mass spectra (HRMS) were obtained on an Agilent 6200 Series TOF with an 
Agilent G1978A Multimode source in electrospray ionization (ESI), atmospheric pressure 
chemical ionization (APCI) or mixed (MultiMode ESI/APCI) ionization mode. Optical 
rotations were measured on a Jasco P-2000 polarimeter using a 100 mm path-length cell at 
589 nm.
8.2. Experimental procedures
8.2.1. (S)-4-(tert-Butyl)-2-(pyridin-2-yl)-4,5-dihydrooxazole (14)—The ligand was 
prepared according to literature procedures.14,23 All characterization data match previously 
reported data.
8.3. Representative general procedure for the enantioselective 1,4-addition of arylboronic 
acids to β-substituted cyclic enones
A screw-top 1 dram vial was charged with a stir bar, Pd(O-COCF3)2 (4.2 mg, 0.0125 mmol, 
5 mol %), (S)-t-BuPyOx (3.1 mg, 0.015 mmol, 6 mol %), and PhB(OH)2 (61 mg, 0.50 
mmol, 2.0 equiv). The solids were dissolved in dichloroethane (0.5 mL) and 3-methyl-2-
cyclohexenone (29 μL, 0.25 mmol) was added. The walls of the vial were rinsed with an 
additional portion of dichloroethane (0.5 mL). The vial was capped with a Teflon/silicone 
septum and stirred at 60 °C in an oil bath for 12 h. Upon complete consumption of the 
starting material (monitored by TLC, 4:1 hexanes/EtOAc, p-anisaldehyde stain) the reaction 
was purified directly by column chromatography (5:1 hexanes/EtOAc) to afford a clear 
colorless oil (47 mg, 99% yield).
8.4. General procedure for the synthesis of racemic products
Racemic products were synthesized in a manner analogous to the general procedure using 
bipyridine (2.1 mg, 0.015 mmol, 6 mol %) as an achiral ligand.
8.5. Spectroscopic data for enantioenriched β,β-disubstituted cyclic ketones
8.5.1. (R)-3-Phenyl-3-methylcyclohexanone (3)—Synthesized according to the 
general procedure and purified by flash chromatography (CH2Cl2) to afford a colorless oil 
(93% yield).  (c 1.36, CHCl3, 92% ee). All characterization data match 
previously reported data.9a,9b,4k,4f,4i,4c,13
8.5.2. (R)-3-(4-Methylphenyl)-3-methylcyclohexanone (36)—Synthesized according 
to the general procedure and purified by flash chromatography (CH2Cl2) to afford a 
colorless oil (99% yield).  (c 1.11, CH2Cl2, 87% ee). All characterization data 
match previously reported data.9a,4i,k
8.5.3. (R)-3-(4-Ethylphenyl)-3-methylcyclohexanone (37)—Synthesized according 
to the general procedure and purified by flash chromatography (hexanes/EtOAc=100:0 to 
95:5) to afford a colorless oil (90% yield). 1H NMR (500 MHz, CDCl3) δ 7.23 (ddd, J=2.0, 
8.5 Hz, 2H), 7.16 (ddd, J=2.0, 8.5 Hz, 2H), 2.87 (d, J=14.0 Hz, 1H), 2.62 (q, J=7.5, 2H), 
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2.42 (d, J=14.0 Hz, 1H), 2.35–2.26 (m, 2H), 2.20–2.15 (m, 1H),1.93–1.83 (m, 2H),1.73–
1.64 (m, 1H),1.31 (s, 3H), 1.23 (t, J=7.5 Hz, 3H); 13C NMR (125 MHz, CDCl3) δ 211.6, 
144.7, 142.0, 127.9, 125.5, 53.2, 42.5, 40.8, 38.0, 29.8, 28.2, 22.0, 15.4; IR (Neat Film, 
NaCl): 2957, 2933, 2863, 1710, 1513, 1453, 1416, 1315, 1288, 1226, 1078 cm−1; HRMS 
(MultiMode ESI/APCI) m/z calcd for C15H21O [M+H]+: 217.1587, found 217.1592; 
 (c 1.61, CHCl3, 85% ee).
8.5.4. (R)-3-(4-Benzyloxylphenyl)-3-methylcyclohexanone (38)—Synthesized 
according to the general procedure and purified by flash chromatography (hexanes/
EtOAc=100:0 to 95:5) to afford a colorless oil (96% yield). 1H NMR (500 MHz, CDCl3) δ 
7.43 (ddd, J=1.5, 2.0, 7.5 Hz, 2H), 7.39 (ddd, J=1.0, 7.0, 7.5, 2H), 7.33 (tt, J=1.5, 7.0 Hz, 
1H), 7.22 (ddd, J=2.0, 3.5, 10.0 Hz, 2H), 6.93 (ddd, J=2.0, 3.5, 10.0 Hz, 2H), 5.04 (s, 2H), 
2.85 (d, J=14.0 Hz, 1H), 2.42 (d, J=14.0 Hz, 1H), 2.30 (t, J=7.0 Hz, 2H), 2.18–2.13 (m, 1H), 
1.92–1.83 (m, 2H), 1.71–1.62 (m, 1H), 1.30 (s, 3H), 0.97 (s, 9H), 0.19 (s, 6H); 13C NMR 
(125 MHz, CDCl3) δ 211.6, 157.0, 139.7, 137.0, 128.6, 127.9, 127.5, 126.7, 114.7, 70.0, 
53.3, 42.3, 40.8, 38.0, 30.0, 22.0; IR (Neat Film, NaCl) 3066, 3027, 2947, 2873, 1710, 1609, 
1579, 1510, 1453, 1426, 1379, 1312, 1290, 1246, 1181, 1021 cm−1; HRMS (MultiMode 
ESI/APCI) m/z calcd for C20H23O2 [M+H]+: 295.1693, found 295.1673;  (c 
4.90, CHCl3, 74% ee).
8.5.5. (R)-3-(4-Methoxyphenyl)-3-methylcyclohexanone (39)—Synthesized 
according to the general procedure and purified by flash chromatography (hexanes/
EtOAc=100:0 to 90:10) as colorless oil (58% yield).  (c 1.05, CHCl3, 69% ee). 
All characterization data match previously reported data.9b,4k,f,c,i
8.5.6. (R)-3-(4-Acetylphenyl)-3-methylcyclohexanone (40)—Synthesized according 
to the general procedure and purified by flash chromatography (CH2Cl2/EtOAc=100:0 to 
98:2) to afford colorless oil (99% yield). 1H NMR (500 MHz, CDCl3) δ 7.92 (ddd, J=2.0, 
9.0 Hz, 2H), 7.42 (ddd, J=2.0, 9.0 Hz, 2H), 2.90 (d, J=14.0 Hz, 1H), 2.58 (s, 3H), 2.47 (d, 
J=14.0 Hz, 1H), 2.38–2.26 (m, 2H), 2.25–2.20 (m, 1H), 1.98–1.88 (m, 2H), 1.68–1.59 (m, 
1H), 1.34 (s, 3H); 13C NMR (125 MHz, CDCl3) δ 210.8, 197.6, 152.9, 135.2, 128.6, 125.9, 
52.8, 43.2, 40.7, 37.8, 29.7, 26.5, 22.0; IR (Neat Film, NaCl) 2957, 2868, 1708, 1683, 1607, 
1569, 1456, 1421, 1404, 1359, 1312, 1268, 1228, 1194 cm−1; HRMS (MultiMode ESI/
APCI) m/z calcd for C15H19O [M+H]+: 231.1379, found 231.1380;  (c 1.39, 
CHCl3, 96% ee).
8.5.7. (R)-3-(4-Trifluoromethylphenyl)-3-methylcyclohexanone (41)—Synthesized 
according to the general procedure and purified by flash chromatography (hexanes/
EtOAc=100:0 to 95:5) to afford a colorless oil (99% yield).  (c 0.92, CHCl3, 
96% ee). All characterization data match previously reported data.4k,f,i
8.5.8. (R)-3-(4-Chlorophenyl)-3-methylcyclohexanone (42)—Synthesized according 
to the general procedure and purified by flash chromatography (hexanes/EtOAc=100:0 to 
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95:5) to afford a white solid (94% yield).  (c 0.56, CHCl3, 95% ee). All 
characterization data match previously reported data.9b
8.5.9. (R)-3-(4-Fluorophenyl)-3-methylcyclohexanone (43)—Synthesized according 
to the general procedure and purified by flash chromatography (hexanes/EtOAc=100:0 to 
95:5) to afford a colorless oil (84% yield).  (c 1.00, CHCl3, 92% ee). All 
characterization data match previously reported data.9a,b
8.5.10. (R)-3-(4-tert-Butyldimethylsiloxylphenyl)-3-methylcyclohexanone (44)—
Synthesized according to the general procedure and purified by flash chromatography 
(hexanes/EtOAc=100:0 to 95:5) to afford a colorless oil (52% yield). 1H NMR (500 MHz, 
CDCl3) δ 7.15 (ddd, J=2.0, 3.0, 9.0 Hz, 2H), 6.71 (ddd, J=2.0, 3.0, 9.0 Hz, 2H), 2.83 (d, 
J=14.0 Hz, 1H), 2.40 (d, J=14.0 Hz, 1H), 2.30 (t, J=7.0 Hz, 2H), 2.16–2.10 (m, 1H), 1.90–
1.81 (m, 2H), 1.70–1.61 (m, 1H), 1.29 (s, 3H), 0.97 (s, 9H), 0.19 (s, 6H); 13C NMR (125 
MHz, CDCl3) δ 211.7, 153.8, 140.1, 126.5, 119.8, 53.3, 42.3, 40.8, 38.1, 29.9, 25.6, 22.0, 
18.1, −4.4; IR (Neat Film, NaCl) 2952, 2933, 2858, 1713, 1607, 1510, 1473, 1458, 1263, 
1181 cm−1; HRMS (MultiMode ESI/APCI) m/z calcd for C19H31O2Si [M+H]+: 319.2088, 
found 319.2090;  (c 1.11, CHCl3, 82% ee).
8.5.11. (R)-3-Methyl-3-(m-tolyl)cyclohexanone (45)—Synthesized according to the 
general procedure and purified by flash chromatography (CH2Cl2) to afford a colorless oil 
(99% yield).  (c 2.95, CH2Cl2, 91% ee). All characterization data match 
previously reported data.9a,4k,f
8.5.12. (R)-3-(3-Methoxycarbonylphenyl)-3-methylcyclohexanone (46)—
Synthesized according to the general procedure and purified by flash chromatography 
(CH2Cl2/EtOAc 100:0 to 98:2) to afford a white solid (91% yield). 1H NMR (500 MHz, 
CDCl3) δ 8.03 (dd, J=1.5, 2.0 Hz, 1H), 7.88 (dd, J=1.5, 9.0 Hz, 1H), 7.51 (dd, J=2.0, 9.0 Hz, 
1H), 7.39 (dd, J=9.0 Hz, 1H), 3.91 (s, 3H), 2.88 (d, J=14.0 Hz, 1H), 2.47 (d, J=14.0 Hz, 
1H), 2.37–2.28 (m, 2H), 2.24–2.19 (m, 1H), 1.98–1.86 (m, 2H), 1.73–1.65 (m, 1H), 1.33 (s, 
3H); 13C NMR (125 MHz, CDCl3) δ 210.9, 167.1, 147.9, 130.4, 130.2, 128.6, 127.5, 126.7, 
53.0, 52.1, 42.8, 40.7, 37.7, 29.3, 22.0; IR (Neat Film, NaCl) 2952, 2878, 1720, 1604, 1582, 
1438, 1350, 1310, 1273, 1243, 1209, 1194, 1120, 1085 cm−1; HRMS (MultiMode ESI/
APCI) m/z calcd for C15H19O3 [M+H]+: 247.1329, found 247.1334;  (c 1.39, 
CHCl3, 95% ee).
8.5.13. (R)-3-(3-Chlorophenyl)-3-methylcyclohexanone (47a)—Synthesized 
according to the general procedure and purified by flash chromatography (hexanes/
EtOAc=100:0 to 95:5) to afford a colorless oil (55% yield).  (c 1.48, CHCl3, 
96% ee). All characterization data match previously reported data.9a,b
8.5.14. (R)-3-(3-Bromophenyl)-3-methylcyclohexanone (47b)—Synthesized 
according to the general procedure and purified by flash chromatography (CH2Cl2) to afford 
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a colorless oil (44% yield).  (c 0.68, CHCl3, 85% ee). All characterization data 
match previously reported data.4i
8.5.15. (R)-3-(3-Nitrophenyl)-3-methylcyclohexanone (47c)—Synthesized 
according to the general procedure and purified by flash chromatography (CH2Cl2) to afford 
a colorless oil (40% yield). 1H NMR (500 MHz, CDCl3) δ 8.22 (t, J=2.0 Hz, 1H), 8.08 (ddd, 
J=1.0, 2.0, 8.0 Hz, 1H), 7.66 (ddd, J=1.0, 2.0, 8.0 Hz, 1H), 7.50 (t, J=8.0 Hz, 1H), 2.88 (d, 
J=14.0 Hz, 1H), 2.53 (ddd, J=1.0, 1.5, 14.0 Hz, 1H), 2.41–2.31 (m, 2H), 2.26–2.20 (m, 1H), 
2.03–1.90 (m, 2H), 1.74–1.66 (m, 1H), 1.37 (s, 3H); 13C NMR (125 MHz, CDCl3) δ 210.1, 
149.7, 148.6, 131.9, 129.5, 121.4, 120.7, 52.8, 43.1, 40.6, 37.6, 29.4, 22.0; IR (Neat Film, 
NaCl) 2957, 2873, 1713, 1525, 1480, 1453, 1426, 1347, 1298, 1226, 1107, 1075 cm−1; 
HRMS (MultiMode ESI/APCI) m/z calcd for C13H15O3N [M]: 233.1052, found 233.1055; 
 (c 0.96, CHCl3, 92% ee).
8.5.16. (R)-3-(2-Fluorophenyl)-3-methylcyclohexanone (47d)—Synthesized 
according to the general procedure and purified by flash chromatography (hexanes/
EtOAc=100:0 to 95:5) to afford a colorless oil (32% yield). 1H NMR (500 MHz, CDCl3) δ 
7.25–7.19 (m, 2H), 7.07 (ddd, J=1.5, 2.0, 7.5 Hz, 2H), 7.39 (ddd, J=1.0, 7.0, 7.5 Hz, 2H), 
7.33 (tt, J=1.5, 7.0 Hz, 1H), 7.22 (ddd, J=1.5, 7.5 Hz, 1H), 7.02 (ddd, J=1.5, 8.0, 13.0 Hz, 
1H), 2.94 (d, J=14.5 Hz, 1H), 2.44 (d, J=14.5 Hz, 1H), 2.48–2.44 (m, 1H), 2.37–2.28 (m, 
2H),1.96–1.87 (m, 2H), 1.67–1.60 (m, 1H), 1.41 (s, 3H), 13C NMR (125 MHz, CDCl3) δ 
211.3, 128.3, 128.0, 127.9, 124.1, 116.7, 53.2, 42.4, 40.9, 35.7, 27.1; IR (Neat Film, NaCl) 
2957, 2933, 2873, 1710, 1611, 1577, 1488, 1443, 1315, 1290, 1214, 1117, 1083 cm−1; 
HRMS (MultiMode ESI/APCI) m/z calcd for C13H16OF [M+H]+: 207.1180, found 
207.1188;  (c 0.64, CHCl3, 77% ee).
8.5.17. (R)-3-Phenyl-3-ethylcyclohexanone (48)—Synthesized according to the 
general procedure and purified by flash chromatography (hexanes/EtOAc=100:0 to 95:5) to 
afford a colorless oil (96% yield).  (c 3.39, CHCl3, 92% ee). All characterization 
data match previously reported data.4c,i,k,9a
8.5.18. (R)-3-Phenyl-3-n-butylcyclohexanone (49)—Synthesized according to the 
general procedure and purified by flash chromatography (hexanes/EtOAc=100:0 to 95:5) to 
afford colorless oil (95% yield).  (c 1.48, CHCl3, 91% ee). All characterization 
data match previously reported data.4c
8.5.19. (R)-3-Benzyl-3-phenylcyclohexanone (50)—Synthesized according to the 
general procedure and purified by flash chromatography (hexanes/EtOAc=100:0 to 95:5) to 
afford a colorless oil (74% yield). (c 3.83, CHCl3, 91% ee). All characterization 
data match previously reported data.13
8.5.20. (R)-3-Phenyl-3-iso-propylcyclohexanone (51)—Synthesized according to the 
general procedure and purified by flash chromatography (hexanes/EtOAc=100:0 to 95:5) to 
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afford a colorless oil (86% yield).  (c 3.24, CHCl3, 79% ee). All characterization 
data match previously reported data.13
8.5.21. (R)-3-Phenyl-3-cyclopropylcyclohexanone (52)—Synthesized according to 
the general procedure and purified by flash chromatography (CH2Cl2) to afford a colorless 
oil (68% yield). 1H NMR (500 MHz, CDCl3) δ 7.30–7.28 (m, 4H), 7.21–7.17 (m, 1H), 2.90 
(dt, J=2.0, 14.5 Hz, 1H), 2.48 (d, J=14.5 Hz, 1H), 2.31–2.19 (m, 3H), 1.94–1.86 (m, 2H), 
1.60–1.51 (m, 1H), 0.99 (tt, J=5.5, 8.5, 1H), 0.45–0.39 (m, 1H), 0.35–0.29 (m, 1H), 0.24–
0.19 (m, 1H), 0.17–0.12 (m, 1H); 13C NMR (125 MHz, CDCl3) δ 210.8, 143.2, 127.6, 
126.5, 125.7, 50.0, 44.9, 40.3, 34.1, 23.1, 20.8, 1.1, 0.0; IR (Neat Film, NaCl) 3081, 3057, 
3007, 2947, 2873, 1708, 1498, 1443, 1421, 1315, 1285, 1226, 1046, 1023 cm−1; HRMS 
(MultiMode ESI/APCI) m/z calcd for C15H19O [M+H]+: 215.1430, found 215.1425; 
 (c 1.39, CHCl3, 88% ee).
8.5.22. (R)-3-Phenyl-3-cyclohexylcyclohexanone (53)—Synthesized according to 
the general procedure and purified by flash chromatography (hexanes/EtOAc=100:0 to 95:5) 
to afford a colorless oil (86% yield). 1H NMR (500 MHz, CDCl3) δ 7.29 (ddd, J=2.0, 7.0, 
8.0 Hz, 2H), 7.23 (ddd, J=1.0, 2.0, 8.0 Hz, 2H), 7.18 (tt, J=1.0, 7.0 Hz, 1H), 2.97 (dd, 
J=2.0,15.0 Hz,1H), 2.46 (d, J=15.0 Hz,1H), 2.26–2.17 (m, 3H), 2.07 (ddd, J=3.5, 12.5, 13.5 
Hz, 1H), 1.94–1.88 (m, 1H), 1.84–1.75 (m, 2H), 1.68–1.56 (m, 2H), 1.52–1.45 (m, 1H), 
1.44–1.38 (m, 1H), 1.37–1.31 (m, 1H), 1.26–1.17 (m, 1H), 1.11–0.95 (m, 2H), 0.88–0.75 
(m, 2H); 13C NMR (125 MHz, CDCl3) δ 212.0, 143.8, 128.1, 127.4, 125.9, 49.5, 49.0, 47.2, 
41.0, 33.6, 27.5, 27.4, 26.9, 26.5, 21.4; IR (Neat Film, NaCl) 2928, 2853, 1713, 1495, 1443, 
1315, 1285, 1228 cm−1; HRMS (MultiMode ESI/APCI) m/z calcd for C18H24O [M+H]+: 
257.1900, found 257.1888;  (c 3.87, CHCl3, 85% ee).
8.5.23. (S)-3-(3-(Benzyloxy)propyl)-3-phenylcyclohexanone (54)—Synthesized 
according to the general procedure and purified by flash chromatography (hexanes/
EtOAc=100:0 to 95:5) to afford a colorless oil (65% yield). 1H NMR (500 MHz, CDCl3) δ 
7.33–7.28 (m, 4H), 7.27–7.24 (m, 5H), 7.18 (tt, J=1.5, 7.0 Hz, 1H), 4.37 (s, 2H), 3.30 (dt, 
J=1.5, 6.5 Hz, 2H), 2.93 (d, J=14.5 Hz, 1H), 2.43 (d, J=14.5 Hz, 1H), 2.33–2.26 (m, 2H), 
2.22–2.16 (m, 1H), 1.98 (ddd, J=3.0, 10.0, 13.5 Hz, 1H), 1.86–1.77 (m, 2H), 1.68 (ddd, 
J=4.5, 12.0 Hz, 1H), 1.61–1.53 (m, 1H), 1.43–1.32 (m, 1H), 1.23–1.14 (m, 1H); 13C NMR 
(125 MHz, CDCl3) δ 211.2, 144.8, 138.4, 128.5, 128.3, 127.6, 127.5, 126.4, 126.2, 72.7, 
70.4, 51.0, 45.9, 41.0, 39.7, 36.6, 23.9, 21.4; IR (Neat Film, NaCl) 3057, 3027, 2947, 2858, 
1710, 1602, 1495, 1451, 1359, 1312, 1280, 1228, 1100, 1075, 1026 cm−1; HRMS 
(MultiMode ESI/APCI) m/z calcd for C22H26O2 [M+H]+: 323.2006, found 323.1993; 
 (c 4.25, CHCl3, 91% ee).
8.5.24. (R)-3-Phenyl-3-methylcyclopentanone (55)—Synthesized according to the 
general procedure and purified by flash chromatography (hexanes/EtOAc=100:0 to 95:5) to 
afford a colorless oil (84% yield).  (c 1.51, CHCl3, 91% ee). All characterization 
data match previously reported data.4f,i,k
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8.5.25. (R)-3-Phenyl-3-methylcycloheptanone (56)—This product was synthesized 
according to the general procedure and purified by flash chromatography (hexanes/
EtOAc=100:0 to 95:5) to afford a colorless oil (85% yield).  (c 1.34, CHCl3, 
93% ee). All characterization data match previously reported data.4i,k,9a
8.6. General procedure for the synthesis of 3-acetyl-3-aryl cyclic ketones
8.6.1. (S)-3-Acetyl-3-phenylcyclopentanone (64e)—A screw-top 1 dram vial was 
charged with a stir bar, Pd(OCOCF3)2 (3.4 mg, 0.01 mmol, 5 mol %), (S)-t-BuPyOx (2.5 
mg, 0.012 mmol, 6 mol %), and PhB(OH)2 (48 mg, 0.40 mmol, 2.0 equiv). The solids were 
suspended in dichloroethane (1 mL) and stirred at ambient temperature for 5 min, at which 
time a yellow color was observed. 3-Acetylcyclopent-2-enone (25 mg, 0.20 mmol, 1 equiv) 
and water (50 μL, 10 equiv) were added and the vial was capped with a Teflon/silicone 
septum and stirred at 60 °C in a heat block for 12 h. Upon complete consumption of the 
starting material (monitored by TLC, 20% acetone/hexanes, p-anisaldehyde stain) the 
reaction was purified directly by column chromatography (eluent gradient: 10% acetone/
hexanes to 20% acetone/hexanes) to afford a clear colorless oil (29 mg, 72% yield). 1H 
NMR (500 MHz, CDCl3) δ 7.44–7.24 (m, 5H), 3.13 (ddd, J=18.0, 1.7, 0.7 Hz, 1H), 2.77–
2.69 (m,1H), 2.53 (dt, J=17.9, 0.8 Hz,1H), 2.47–2.37 (m,1H), 2.32 (dddd, J=8.5, 6.8, 4.1, 
0.9 Hz, 2H), 1.97 (d, J=0.6 Hz, 3H); 13CNMR(125 MHz, CDCl3) δ 214.9, 207.7,140.7, 
129.2, 127.7, 126.5, 61.2, 47.1, 36.5, 30.8, 25.4; IR (Neat Film, NaCl): 3059, 
3026,1745,1705,159,1495,1446,1407,1355,1203,1151 cm−1; HRMS (MultiMode ESI/
APCI) m/z calcd for C13H15O2 [M+H]+: 203.1072, found 203.1066;  (c 1.5, 
CHCl3, 93% ee).
8.6.2. (R)-3-(4-Chloropheny)-3-acetylcyc lohexanone (64a)—Synthesized 
according to the general procedure, 0.25 mmol scale. The title compound was isolated as an 
off-white solid (53 mg, 85% yield). 1H NMR (300 MHz, CDCl3) δ 7.35 (m, 2H), 7.18 (m, 
2H), 2.85 (dt, J=1.4, 14.8 Hz, 1H), 2.63 (dt, J=1.1, 14.8 Hz, 1H), 2.48–2.20 (m, 4H), 1.87 (s, 
3H), 1.80–1.69 (m, 2H); 13C NMR (125 MHz, CDCl3) 208.3, 208.1, 139.3, 133.8, 129.5, 
127.8, 59.6, 48.6, 40.3, 31.5, 25.3, 21.1; FTIR (Neat Film, NaCl) 3397, 2951, 
2875,1708,1490,1455,1420, 1402, 1356, 1319, 1235, 1183, 1140, 1097, 1012, 970, 829, 717 
cm−1; HRMS (MultiMode ESI/APCI) m/z calcd for C14H15ClO2 [M+H]+: 251.0833, found: 
251.0829;  (c 3.2, CHCl3, 96% ee).
8.6.3. (S)-3-Acetyl-3-(4-fluorophenyl)cyclohexanone (64b)—Synthesized according 
to the general procedure, 0.22 mmol scale. Title compound isolated as a pale yellow oil (45 
mg, 92% yield). 1H NMR (500 MHz, CDCl3) δ 7.26–7.19 (m, 2H), 7.11–7.03 (m, 2H), 2.87 
(dt, J=14.8, 1.5 Hz, 1H), 2.65 (dt, J=14.8, 1.3 Hz, 1H), 2.38–2.34 (m, 2H), 2.32–2.24 (m, 
2H), 1.88 (s, 3H) 1.80–1.71 (m, 2H); 13C NMR (125 MHz, CDCl3) δ 208.1, 208.0, 162.1 (d, 
JC-F=247.8 Hz), 136.3 (d, JC-F=3.3 Hz), 128.1 (d, JC-F=8.1 Hz), 116.1 (d, JC-F=21.4 Hz), 
59.3, 48.5, 40.1, 31.6, 25.0, 20.9; IR (Neat Film, NaCl): 2950, 1708, 1601, 1510, 1355, 
1231, 1186, 1164 cm−1; HRMS (MultiMode ESI/APCI) m/z calcd for C14H16FO2 [M+H]+: 
235.1134, found 235.1132;  (c 1.5, CHCl3, 90% ee).
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8.6.4. (S)-3-Acetyl-3-(m-tolyl)cyclohexanone (64c)—Synthesized according to the 
general procedure, 0.22 mmol scale. Title compound isolated as an off-white solid (33 mg, 
66% yield). 1H NMR (500 MHz, CDCl3) δ 7.30–7.23 (m, 1H), 7.14–7.01 (m, 3H), 2.87 (dt, 
J=14.9, 1.6 Hz, 1H), 2.65 (dt, J=14.8, 1.2 Hz, 1H), 2.48–2.22 (m, 7H), 1.92–1.66 (m, 
5H); 13C NMR (125 MHz, CDCl3) δ 208.5, 140.6, 138.9, 129.1, 128.3, 126.9, 123.3, 59.7, 
48.6, 40.2, 31.4, 25.1, 21.5, 21.0; IR (Neat Film, NaCl): 2949, 1708, 1558, 1456, 1354, 
1182, 1158 cm−1; HRMS (MultiMode ESI/APCI) m/z calcd for C15H19O2 [M+H]+: 
231.1385, found 231.1383;  (c 1.6, CHCl3, 92% ee).
8.6.5. (S)-N-(5-(1-Acetyl-3-oxocyclohexyl)-2-methylphenyl)-2,2,2-
trifluoroacetamide (64d)—Synthesized according to the general procedure, 0.22 mmol 
scale. Title compound isolated as an off-white solid (54 mg, 73% yield). 1H NMR (500 
MHz, CDCl3) δ 7.98–7.94 (m, 1H), 7.73 (dt, J=5.2, 2.5 Hz, 1H), 7.27 (t, J=4.0 Hz, 1H), 7.06 
(dd, J=8.1, 2.0 Hz, 1H), 2.90 (d, J=14.9 Hz, 1H), 2.60 (d, J=15.0 Hz, 1H), 2.50–2.41 (m, 
1H), 2.41–2.21 (m, 7H), 1.91 (s, 3H), 1.90–1.79 (m, 1H), 1.78–1.66 (m, 1H); 13C NMR (125 
MHz, CDCl3) δ 208.2, 208.0,155.1 (q, JC-F=37.2 Hz),139.8, 133.7, 131.7,129.8, 125.1, 
121.4, 115.9 (q, JC-F=288.8 Hz), 59.6, 48.6, 40.0, 31.2, 25.1, 21.0, 16.9; IR (Neat Film, 
NaCl): 3279, 2954, 1708, 1541, 1506, 1356, 1256, 1201, 1158 cm−1; HRMS (MultiMode 
ESI/APCI) m/z calcd for C17H19O3F3N [M+H]+: 342.1317, found 342.1313;  (c 
1.1, CHCl3, 91% ee).
8.6.6. (S)-3-Acetyl-3-(m-tolyl)cyclopentanone (64f)—Synthesized according to the 
general procedure, the title compound was isolated as a pale yellow oil (31 mg, 72% 
yield). 1H NMR (500 MHz, CDCl3) δ 7.32–7.25 (m, 1H), 7.14 (dddt, J=7.6, 1.9, 1.3, 0.6 Hz, 
1H), 7.10–7.03 (m, 2H), 3.10 (ddd, J=18.0, 1.7, 0.8 Hz, 1H), 2.71 (dddd, J=13.0, 7.7, 5.5, 
1.7 Hz, 1H), 2.57–2.49 (m, 1H), 2.46–2.27 (m, 6H), 1.98 (s, 3H); 13C NMR (125 MHz, 
CDCl3) δ 215.2, 207.9, 140.7, 138.9, 129.0, 128.50, 127.2, 123.5, 123.5, 47.1, 36.5, 30.8, 
25.3, 21.5; IR (Neat Film, NaCl): 2921, 1745, 1704, 1605, 1489, 1407, 1354, 1150 cm−1; 
HRMS (MultiMode ESI/APCI) m/z calcd for C14H17O2 [M+H]+: 217.1229, found 
217.1218;  (c 1.5, CHCl3, 90% ee).
8.6.7. (S)-3-Acetyl-3-(4-fluorophenyl)cyclopentanone (64g)—Synthesized 
according to the general procedure, the title compound was isolated as a pale yellow oil (25 
mg, 57% yield). 1H NMR (500 MHz, CDCl3) δ 7.29–7.21 (m, 2H), 7.14–7.06 (m, 2H), 3.12 
(dd, J=17.8, 1.7 Hz, 1H), 2.78–2.69 (m, 1H), 2.49 (dd, J=17.9, 0.9 Hz, 1H), 2.43–2.27 (m, 
3H), 1.97 (s, 3H); 13C NMR (125 MHz, CDCl3) δ 214.5, 207.4, 162.2 (d, JC-F=247.8 Hz), 
136.6 (d, JC-F=3.3 Hz), 128.2 (d, JC-F=8.2 Hz), 116.1 (d, JC-F=21.5 Hz), 60.6, 47.2, 36.5, 
30.9, 25.2; IR (Neat Film, NaCl): 2925, 1745, 1704, 1599, 1509, 1408, 1355, 1223, 1142 
cm−1; HRMS (MultiMode ESI/APCI) m/z calcd for C13H14O2F [M+H]+: 221.0978, found 
221.0984;  (c 1.0, CHCl3, 92% ee).
8.7. Representative procedure for the synthesis of N-trifluoroacetamide boronic acids
8.7.1. N-(3-Bromophenyl)-2,2,2-trifluoroacetamide—In a 100 mL round bottom 
flask were added consecutively 3-bromoaniline (1.7 g, 10.0 mmol, 1 equiv), DMAP (0.12 g, 
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1.0 mmol, 0.1 equiv), 20 mL of CH2Cl2 and Et3N (1.7 mL, 12.0 mmol, 1.2 equiv). The 
solution was cooled to 0 °C and trifluoroacetic anhydride (2.1 mL, 15.0 mmol, 1.5 equiv) 
was added dropwise. The obtained mixture was stirred at room temperature until all the 
starting material was consumed (TLC hexane/EtOAc 4:1) and then it was extracted with 
CH2Cl2 (3 × 20 mL) and washed with brine (2 × 20 mL). The combined organic phases 
were dried with MgSO4 and the solvent was evaporated to give an off-white solid that was 
purified via silica gel column chromatography (2.35 g, 88% yield). 1H NMR (300 MHz, 
CDCl3) δ 7.84 (t, J=2.0 Hz, 1H), 7.80 (br s, 1H), 7.51 (dd, J=8.1, 1.2 Hz, 1H), 7.39 (d, J=8.2 
Hz, 1H), 7.30–7.24 (m, 1H); 13C NMR (125 MHz, CDCl3) δ 155.1 (q, JC-F=37.7 Hz), 136.3, 
130.7, 129.7, 123.8, 123.0, 119.3, 115.6 (q, JC-F=288.5 Hz); 19F NMR (282 MHz, CDCl3) δ 
−75.72, −75.73; FTIR (Neat Film, NaCl) 3288, 1709, 1593, 1538, 1470, 1429, 1338, 1263, 
1251, 1171, 1153, 1069, 997, 975, 925, 873, 865, 785, 739 cm−1; HRMS (MultiMode ESI/
APCI) m/z calcd for C8H5BrF3NO [M−H]−: 265.9434, found: 295.9426.
8.7.2. 3-(2,2,2-Trifluroacetamide)-phenylboronic acid (65f)—A flame dried one 
neck round bottom flask was charged with the required trifluoroacetanilide (1.0 g, 3.7 mmol, 
1 equiv). The flask was sealed, evacuated, and backfilled with argon. THF (20 mL) was 
added via syringe and the obtained mixture was cooled to −78 °C. n-BuLi (2.3 M solution in 
hexane, 3.6 Ml, 8.2 mmol, 2.2 equiv) was added dropwise and the obtained mixture was 
stirred for 2 h at this temperature. Triisopropylborate (2.7 mL, 11.7 mmol, 3 equiv) was then 
added via syringe and the mixture was stirred for 10 min at −78 °C and for 1 h at room 
temperature. A solution of HCl (2 M in water, 10 mL) was added and the biphasic mixture 
was vigorously stirred for another hour and then extracted with EtOAc (3 × 30 mL). The 
combined organic phases were washed with brine (2 × 20 mL) and dried over MgSO4. Upon 
evaporation of the solvent under reduced pressure an off-white solid was obtained. It was 
suspended in hexane and stirred until a fine powderwas formed. Itwas filtered and dried in 
high vacuum for 30 min (0.58 g, 67% yield). (General note for all trifluoroacetamide 
substrates: If the obtained product is not clean from NMR analysis then a 10:1 mixture of 
hexane/Et2O or hexane/CH2Cl2 can be used instead of hexanes to suspend the compound. If 
the crude aryl boronic acid is obtained as an oil and does not solidify, then add ether, water, 
and a 1Msolution of NaOH (5 equiv) to the crude mixture. After extraction, the isolated 
water phase can be acidified with a 1 M aqueous HCl solution and extracted with EtOAc. 
The organic phased is washed with water, brine, and concentrated in vacuo. Upon 
evaporation of the solvent and trituration with pentane or hexane the desired product should 
be obtained as an off-white solid.) 1H NMR (300 MHz, acetone-d6) δ 8.11 (br s, 1H), 7.81 
(m, 1H), 7.74 (dt, J=7.4, 1.0 Hz, 1H), 7.40 (t, J=7.7 Hz, 1H), 7.28 (s, 1H); (The obtained 13C 
NMR is complex due to the presence of two rotamers in solution) 13C NMR (125 MHz, 
CDCl3) δ 154.8 (q, J=36.9 Hz), 154.7 (q, J=36.8 Hz), 135.8, 135.7, 131.5, 128.2, 126.7, 
126.6, 123.0, 122.9, 116.2 (q, J=288.1 Hz); 19F NMR (282 MHz, CDCl3) δ −76.22, −76.25; 
FTIR (Neat Film, NaCl): 3305, 1701, 1585, 1554, 1437, 1334, 1264, 1182, 1031, 780 cm−1; 
HRMS (MultiMode ESI/APCI) m/z calcd for C8H7BrF3NO [M−H]−: 231.0435, found: 
231.0433.
8.7.3. 4-(2,2,2-Trifluroacetamide)-phenylboronic acid (65c)—Obtained using the 
representative procedure in 65% yield. 1H NMR (300 MHz, acetone-d6) δ 10.22 (br s, 1H), 
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7.91 (d, J=8.4 Hz, 2H), 7.72 (d, J=8.4 Hz, 1H), 7.20 (s, 1H); 13C NMR (125 MHz, acetone-
d6) δ 155.6 (q, JC-F=37.2 Hz), 136.3, 139.2, 135.9, 120.5, 119.2 (q, JCF =288.3 Hz); 19F 
NMR (282 MHz, acetone-d6) δ −76.21, −76.24; FTIR (Neat Film, NaCl) 3297, 1714, 1595, 
1539, 1408, 1275, 1244, 1183, 1113, 1008, 832, 798 cm−1; HRMS (MultiMode ESI/APCI) 
m/z calcd for C8H7BrF3NO [M−H]−: 231.0435, found: 231.0443.
8.7.4. 4-(2,2,2-Trifluroacetamide)-3-methoxyphenylboronic acid (65d)—Obtained 
as an off-white solid in 35% yield following the general procedure and using the required 
trifluoroacetanilide (1.4 g, 4.9 mmol, 1 equiv), n-BuLi (4.4 mL of a 2.4 M solution, 10.7 
mmol, 2.2 equiv) and triisopropylborate (3.4 mL, 14.6 mmol, 3 equiv). 1H NMR (300 MHz, 
acetone-d6) δ 9.34 (s, 1H), 8.05 (dd, J=3.0, 6.9 Hz, 1H), 7.58 (s 1H), 7.54 (dd, J=7.9,1.0 Hz, 
1H) 7.29 (s, 1H), 3.93 (s, 3H); 13C NMR (125 MHz, acetone-d6) δ 154.3 (q, JC-F =150 Hz), 
149.3, 126.8, 126.6, 120.5, 116.1, 115.8 (q, JC-F=288 Hz), 112.5, 55.4; IR (Neat Film, 
NaCl): 3298, 1708, 1591, 1537, 1503, 1465, 1404, 1342, 1294, 1273, 1224, 1161, 1123, 
1015; HRMS (MultiMode ESI/APCI) m/z calcd for C9H8BO4NF3 [M−H]−: 261.0590, 
found: 261.0497.
8.7.5. 4-(2,2,2-Trifluroacetamide)-2,6-dimethyl-phenylboronic acid (65e)—
Obtained as an off-white solid in 66% yield following the general procedure and using the 
required trifluoroacetanilide (1.0 g, 3.4 mmol, 1 equiv), n-BuLi (3.2 mL of a 2.3 M solution, 
7.44 mmol, 2.2 equiv) and triisopropylborate (2.3 mL, 10.1 mmol, 3 equiv). 1H NMR (300 
MHz, acetone-d6) δ 7.62 (s, 2H), 7.20 (s, 1H), 2.25 (s, 6H); 13C NMR (125 MHz, acetone-
d6) δ 155.1 (q, J=36.5 Hz), 134.2, 134.2, 134.1, 133.9, 116.5 (q, J=286.0 Hz), 17.1; 19F 
NMR (282 MHz, acetone-d6) δ −75.97, −75.99; FTIR (Neat Film, NaCl): 3233, 1705, 1602, 
1533, 1340, 1219, 1192, 1160 cm−1; HRMS (MultiMode ESI/APCI) m/z calcd for 
C10H11NBrF3O [M−H]−: 259.0748, found 259.0749.
8.7.6. 3-(2,2,2-Trifluroacetamide)-4-methylphenylboronic acid (65g)—Obtained 
as an off-white solid in 66% yield following the general procedure and using the required 
trifluoroacetanilide (2.0 g, 3.7 mmol, 1 equiv), n-BuLi (3.6 mL of a 2.3 M solution, 8.2 
mmol, 2.2 equiv) and triisopropylborate (2.6 mL, 11.2 mmol, 3 equiv). 1H NMR (300 MHz, 
acetone-d6) δ 7.82 (s, 1H), 7.75 (dd, J=6.5, 10 Hz, 1H), 7.32 (d, J=7.5 Hz, 1H) 7.24 (s, 
1H); 13C NMR (125 MHz, acetone-d6) δ 155.4 (q, J=37.5 Hz), 136.2, 133.5, 132.9, 
132.1,130.1,116.4 (q, J=288.0 Hz); FTIR (Neat Film, NaCl) 3270,1708, 1617, 1533, 1406, 
1351, 1259, 1180, 1162, 1092, 1036, 898, 825 cm−1; HRMS (MultiMode ESI/APCI) m/z 
calcd for C9H8BF3NO3 [M−H]−: 245.0477, found 245.0591.
8.8. Representative general procedure for the enantioselective 1,4-addition of arylboronic 
acids to β-substituted cyclic enones
8.8.1. (R)-3-(4-(2,2,2-Tri fluoroacetamide)phenyl)-3-methylcyclohexanone (66c)
—A screw-top 5 mL vial was charged with a stir bar, Pd(OCOF3)2 (4.5 mg, 0.014 mmol, 
0.05 equiv), (S)-t-BuPyOx (3.3 mg, 0.016 mmol, 0.06 equiv), boronic acid (95 mg, 0.41 
mmol, 1.5 equiv), and NH4PF6 (13 mg, 0.08 mmol, 0.3 equiv). Dichloroethane (1 mL) was 
added and the mixture was stirred until a homogeneous suspension was formed (1 min). 3-
Methyl-2-cyclohexenone (30 mg, 0.27 mmol, 1 equiv) was then added dissolved in 1.7 mL 
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of dichloroethane (yields are improved with the addition of enone as a solution). Water (25 
μL, 1.3 mmol, 5 equiv) was added, and the vial was sealed and the reaction was stirred at 60 
°C for 3 h. After this time almost all the solid in the vial was consumed and from TLC 
(hexane/EtOAc 4:1) all the starting enone disappeared. The mixture was cooled to ambient 
temperature and it was charged directly into a silica gel column for purification. The desired 
product was isolated as white powder (80 mg, 98% yield, 89% ee SFC column 6 (IC) 5 
mL/min 4% MeOH). 1H NMR (300 MHz, CDCl3) δ 7.91 (br s, 1H), 7.53 (m, 2H), 7.36 (m, 
2H), 2.85 (d, J=14.2 Hz, 1H), 2.45 (d, J=14.0 Hz, 1H), 2.32 (m, 2H), 2.25–2.12 (m, 1H), 
1.98–1.82 (m, 2H), 1.71–1.57 (m, 1H), 1.32 (s, 3H); 13C NMR (125 MHz, CDCl3) δ 211.8, 
154.9 (q, J=37.4 Hz), 145.2, 133.5, 126.7, 120.6, 115.7 (q, J=289.0 Hz), 52.9, 42.9, 40.7, 
37.9, 30.4, 22.0; FTIR (Neat Film, NaCl) 3292, 2958, 1706, 1609, 1545, 1517, 1412, 1285, 
1252, 1193, 1155, 901, 835 cm−1; HRMS (MultiMode ESI/APCI) m/z calcd for 
C15H16F3NO [M−H]−: 298.106, found 289.1049;  (c 2.10, CHCl3, 89% ee).
8.8.2. (R)-3-(4-(N-Carbobenzyloxy)phenyl)-3-methylcyclohexanone (66a)—
Following the general procedure the desired product was obtained as a clear oil (35 mg, 45% 
yield, 76% ee, SFC column 6 (IC) 5 mL/min 15% MeOH). 1H NMR (300 MHz, CDCl3) δ 
7.44–7.30 (m, 6H), 7.25–7.22 (m, 3H), 6.63 (br s,1H), 5.20 (s, 2H), 2.84 (d, J=14.2 Hz, 1H), 
2.42 (d, J=14.1 Hz, 1H), 2.31 (m, 2H), 2.21–2.10 (m, 1H), 1.95–1.80 (m, 2H),1.73–1.60 (m,
1H),1.30 (s, 3H); 13CNMR(125 MHz, CDCl3) δ 211.6, 153.5, 142.7, 136.1, 135.9, 128.7, 
128.5, 128.4, 126.5, 118.9, 67.2, 53.3, 42.6, 40.9, 38.0, 30.1, 22.1; FTIR (Neat Film, NaCl) 
3306, 2953, 1705, 1597, 1534, 1454, 1409, 1323, 1220, 1052 cm−1; HRMS (MultiMode 
ESI/APCI) m/z calcd for C21H24NO3 [M+H]+: 338.1756, found 338.1760;  (c 
1.40, CHCl3, 76% ee).
8.8.3. (R)-3-(4-(N-Pivaloyl)phenyl)-3-methylcyclohexanone (66b)—Following the 
general procedure the desired product was obtained as a white solid (56 mg, 72% yield, 78% 
ee SFC column 5 (OB–H) 5 mL/min 10% MeOH). 1H NMR (300 MHz, CDCl3) δ 7.47 (d, 
J=8.7 Hz, 2H), 7.33–7.24 (m, 2H), 2.85 (d, J=14.2 Hz, 1H), 2.42 (d, J=14.2 Hz, 1H), 2.31 
(m, 2H), 2.21–2.11 (m, 1H), 1.95–1.80 (m, 2H), 1.72–1.58 (m, 1H), 1.31 (s, 9H), 1.29 (s, 
3H); 13C NMR (125 MHz, CDCl3) δ 211.6, 176.7, 143.4, 136.2, 126.3, 120.1, 53.2, 42.7, 
40.9, 39.7, 38.1, 30.1, 27.8, 22.1; FTIR (Neat Film, NaCl) 3379, 2961, 1685, 1594, 1518, 
1400, 1318, 1301, 1255, 1189 cm−1; HRMS (MultiMode ESI/APCI) m/z calcd for 
C18H26NO2 [M+H]+: 288.1964, found 288.1969;  (c 1.01, CHCl3, 78% ee).
8.8.4. (R)-3-(4-(2,2,2-Trifluoroacetamide)-3-methoxyphenyl)-3-
methylcyclohexanone (66d)—Following the general procedure the desired product was 
obtained as white solid (67 mg, 75% yield). 1H NMR (300 MHz, CDCl3) δ 8.50 (br s, 1H), 
8.24 (d, J=8.5 Hz, 2H), 6.96 (dd, J=8.5, 2.1 Hz, 1H), 6.87 (d, J=2.1 Hz, 1H), 3.93 (s, 3H), 
2.87 (d, J=14.1 Hz, 1H), 2.45 (d, J=14.2 Hz, 1H), 2.32 (m, 1H), 2.24–2.14 (m, 1H), 2.0–1.8 
(m, 1H), 1.68–2.5 (m, 1H), 1.32 (s, 3H); FTIR (neat, NaCl): 3362, 2960, 2871, 1706, 1665, 
1594, 1515, 1479, 1402, 1321, 1228, 1193, 1164 cm−1; HRMS (MultiMode ESI/APCI) m/z 
calcd for C16H17F3NO3 [M−OH]: 328.1161, found: 328.1167;  (c 1.25, CHCl3, 
88% ee).
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8.8.5. (R)-3-(4-(2,2,2-Trifluoroacetamide)-2,6-dimethylphenyl)-3-
methylcyclohexanone (66e)—Following the general procedure the desired product was 
obtained in 93% yield as a white solid (90% ee, SFC column 1 (AD-H) 5 mL/min 5% 
MeOH). 1H NMR (300 MHz, CDCl3) δ 7.41 (br s, 1H), 7.05 (s, 2H), 2.84 (d, J=14.2 Hz, 
1H), 2.42 (d, J=14.1 Hz, 1H), 2.32 (m, 2H), 2.24 (s, 6H), 2.21–2.10 (m, 1H), 1.96–1.80 (m, 
2H), 1.76–1.60 (m, 1H), 1.30 (s, 3H); 13C NMR (125 MHz, CDCl3) δ 211.8, 156.2 (q, 
J=36.4 Hz), 147.6, 135.1, 128.9, 125.7, 118.2 (q, J=279.9 Hz), 52.8, 42.4, 40.6, 37.6, 29.4, 
21.9, 18.2; FTIR (Neat Film, NaCl) 2958, 2863, 1715, 1651, 1583, 1568, 1538, 1479, 1441, 
1359, 1314, 1228, 1198, 1157, 1101 cm−1; HRMS (MultiMode ESI/APCI) m/z calcd for 
C17H20F3NO2 [M−H]−: 326.1373, found 326.1370;  (c 2.10, CHCl3, 90% ee).
8.8.6. (R)-3-(3-(2,2,2-Tri fluoroacetamide)phenyl) - 3 - methylcyclohexanone 
(66f)—Following the general procedure the desired product was obtained in 60% yield as 
transparent oil (92% ee, SFC column 1 (AD-H) 5 mL/min 5% MeOH). 1H NMR (300 MHz, 
CDCl3) δ 7.91 (br s, 1H), 7.55–7.45 (m, 2H), 7.36 (t, J=7.9 Hz, 1H), 7.20 (m, 1H), 2.87 (d, 
J=14.2 Hz, 1H), 2.46 (d, J=14.2 Hz, 1H), 2.32 (m, 2H), 2.27–2.17 (m, 1H),1.98–1.82 (m, 
2H),1.71–1.57 (m, 1H),1.33 (s, 3H); 13C NMR (125 MHz, CDCl3) δ 211.5, 154.9 (q, J=37.0 
Hz), 148.9, 135.5, 129.5, 123.6, 118.5, 118.0, 115.6 (q, J=289.2 Hz), 52.9, 43.0, 40.7, 37.8, 
30.0, 22.0; FTIR (Neat Film, NaCl) 3298, 3157, 3111, 2959, 2876,1713, 1616, 1595, 1563, 
1493, 1442, 1421, 1291, 1239, 1201, 1156 cm−1; HRMS (MultiMode ESI/APCI) m/z calcd 
for C15H16F3NO2 [M−H]−: 298.1055, found: 298.1050;  (c 2.10, CHCl3, 92% 
ee).
8.8.7. (R)-3-(3-(2,2,2-Trifluoroacetamide)-4-methylpheny)-3-
methylcyclohexanone (66g)—Following the general procedure the desired product was 
obtained in 77% yield as a white solid (91% ee, OD-H column, 5 mL/min, 5% MeOH). 1H 
NMR (300 MHz, CDCl3) δ 7.94 (br s, 1H), 7.66 (s, 1H), 7.16 (d, J=8.1 Hz, 1H), 7.11 (dd, 
J=8.1, 1.9 Hz, 1H), 2.85 (d, J=14.1 Hz, 1H), 2.44 (d, J=14.1 Hz, 1H), 2.32 (m, 2H), 2.26 (s, 
3H), 2.24–2.07 (m, 1H), 1.97–1.80 (m, 2H), 1.78–1.60 (m, 1H), 1.31 (s, 3H). 13C NMR (125 
MHz, CDCl3) δ 211.3, 156.2 (q, J=36.4 Hz), 146.6, 132.9, 131.4, 130.9, 128.3, 124.4, 118.1 
(q, J=279.8 Hz), 53.0, 42.7, 40.7, 37.7, 29.6, 22.0, 16.9; FTIR (Neat Film, NaCl) 3277, 
3060, 2959, 2873, 1711, 1617, 1577, 1540, 1507, 1452, 1420, 1316, 1281, 1257, 1200, 1162 
cm−1; HRMS (MultiMode ESI/APCI) m/z calcd for C16H18F3NO2 [M+H]+: 314.1362, 
found: 314.1370.  (c 5.3, CHCl3, 88% ee).
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Fig. 1. 
Logical implementation of pyridinooxazoline ligands.
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Fig. 2. 
Plausible catalytic cycle.
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Table 1
Preliminary ligand screena
aConditions: Reactions were performed with phenylboronic acid (0.50 mmol), 3-methylcyclohexen-2-one (0.25 mmol), Pd(OAc)2 (5 mol%), and 
ligand (6 mol%) in solvent (1 mL) for 24 h. NMR yield. ee determined by chiral HPLC.
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Table 2
Preliminary solvent screena
Entry Solvent Temp (°C) Yield (%) eed (%)
1 tert-Amyl alcohol 40 14b –
2 Dioxane 40 17b –
3 THF 40 31b –
4 Toluene 40 65b 82
5 CH2CI2 40 87c 91
6 Toluene 60 63c 77
7 Hexane 60 68c 62
aConditions: Reactions were performed with phenylboronic acid (0.50 mmol), 3-methylcyclohexen-2-one (0.25 mmol), Pd(OCOCF3)2 (5 mol %), 
and (S)-t-BuPyOx (6 mol %) in solvent (1 mL) for 24 h.
bNMR yield.
c
Isolated yield.
d
ee determined by chiral HPLC.
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Table 5
PyOx and QuinOx ligand screena
aConditions: Reactions were performed with phenylboronic acid (0.50 mmol), 3-methylcyclohexen-2-one (0.25 mmol), Pd(OCOCF3)2 (5 mol%), 
and ligand (6 mol%) in ClCH2CH2Cl (1 mL) for 12 h. Isolated yield. ee determined by chiral HPLC.
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Table 6
Expanded ligand screena
aConditions: Reactions were performed with phenylboronic acid (0.50 mmol), 3-methylcyclohexen-2-one (0.25 mmol), Pd(OCOCF3)2 (2.5 mol
%), and ligand (3 mol%) in ClCH2CH2Cl (1 mL) for 12–48 h, unless otherwise noted. Conversion determined by 1H NMR.
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Table 7
Boronic acid substrate scopea
aConditions: Reactions were performed with phenylboronic acid (0.50 mmol), 3-methylcyclohexen-2-one (0.25 mmol), Pd(OCOCF3)2 (5 mol%), 
and ligand 14 (6 mol%) in ClCH2CH2Cl (1 mL) at 40–80 °C for 12–24 h. Isolated yield. ee determined by chiral HPLC.
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Table 8
Increased reaction yields with NH4PF6 and water as reaction additivesa
a
Blue font: reported yield and ee of 47 in the absence of NH4PF6 and water with reactions performed at 60 °C; red font: yield and ee of 47 with 
additives. Conditions: Reactions were performed with phenylboronic acid (1.0 mmol), 3-methylcyclohexen-2-one (0.5 mmol), NH4PF6 (30 mol 
%), water (5 equiv.), Pd(OCOCF3)2 (5 mol%), and (S)-t-BuPyOx (6 mol%) in ClCH2CH2Cl (2 mL) at 40 °C. Isolated yield. ee was determined 
by chiral HPLC.
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Table 9
Enone substrate scopea
aConditions: Reactions were performed with phenylboronic acid (0.50 mmol), cycloalkenone (0.25 mmol), Pd(OCOCF3)2 (5 mol%), and ligand 
14 (6 mol%) in ClCH2CH2Cl (1 mL) at 60 °C for 12 h.
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Table 10
β-Acyl enone substrate scopea
aConditions: Reactions were performed with phenylboronic acid (0.50 mmol), cycloalkenone (0.25 mmol), Pd(OCOCF3)2 (5 mol%), and ligand 
14 (6 mol%) in ClCH2CH2Cl (1 mL) at 60 °C for 12 h.
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Table 11
Trifluoroacetamide boronic acid nucleophilesa
aConditions: Reactions were performed with phenylboronic acid (0.50 mmol), 3-methylcyclohexenone (0.25 mmol), Pd(OCOCF3)2 (5 mol%), and 
ligand 14 (6 mol%) in ClCH2CH2Cl (1 mL) at 60 °C for 12 h.
b
Yield of product (66).
c
ee of product (66).
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Table 12
Challenging enone substratesa
aOptimized reaction conditions afford trace or no conversion as observed by 1H NMR spectroscopy of the crude reaction mixture.
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Table 13
Challenging boronic acid substratesa
aOptimized reaction conditions afford trace or no conversion as observed by 1H NMR spectroscopy of the crude reaction mixture.
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